Trials / Withdrawn
WithdrawnNCT02292459
Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)
A Multicenter, Open Label, Non-controlled Phase 3 Clinical Trial of the Efficacy and the Safety for the Relief of Constipation of Polyethylene Glycol 3350
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the complete resolution of constipation in participants taking PEG 3350 compared to those taking PEG 4000, based on analysis of the number of bowel movements from self-reported bowel movement (BM) data. The complete resolution of constipation is defined as the elimination of straining or of hard/lumpy stools.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Polyethylene Glycol 3350 Powder for Solution (PEG 3350) | |
| DRUG | Polyethylene Glycol 4000 Powder for Solution (PEG 4000) |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-11-17
- Last updated
- 2015-07-16
Source: ClinicalTrials.gov record NCT02292459. Inclusion in this directory is not an endorsement.